Participated · Series A · Jun 2026

Founded in 2020, SOMAREALITY develops real-time cognitive insights derived from eye-tracking data, offering biomarkers such as Cognitive Load and measures of perception, attention and fatigue. Its solution is hardware-agnostic, uses a white-box approach for personalized insights after only seconds of data, and is available both as local integrations and a web-based service, with on-chip deployment planned for wearable glasses. The company has commercial traction in B2B, reporting over €2 million in revenue since launching its first biomarker in 2024 and more than doubling revenue in 2025 through partnerships with global eye-tracking hardware and software distributors. Key markets include high-risk industries such as aviation, healthcare, professional sports and research. SOMAREALITY is pursuing longitudinal studies to track cognitive health and plans to expand into B2C as part of its growth strategy.

Participated · Equity · Jun 2026

Cloov, founded by Chiara Airoldi and Olimpia Santella, launched Uplyst, a software designed to help SMEs publish and manage product listings across multiple online marketplaces. Uplyst uses artificial intelligence and generative capabilities to analyze products, create or import catalogs, and adapt titles, descriptions, and categories to each marketplace's rules. The platform integrates traditional channels such as eBay, Amazon and TikTok Shop as well as next-gen marketplaces, social commerce, AI assistants and automated buying agents. Cloov positions Uplyst as a conversational, self-managed service-as-a-software that reduces the need for configured interfaces or workflows and aims to behave like a scalable dedicated team. The company plans to use new funding to broaden marketplace integrations and add features that further automate sales management and reduce publication errors and duplicate listings. The article notes the appointment of Matteo Tritto as CTO and late co-founder to drive the technical realization of these plans.

Participated · Series A · Jan 2026

Vitrealab is a Vienna-based spin-off from the Quantum Group at the University of Vienna that is building and manufacturing display components for AR glasses. Its core product, the Quantum Light Chip (QLC), is a photonic integrated circuit that houses hundreds of low-loss optical waveguides paired with nano-imprinted micro-optics and multiple RGB laser diodes to generate uniform, collimated light. This micro-scale light engine is intended to dramatically improve brightness and efficiency in AR displays. With its proprietary chip architecture, the company targets partnerships with AR headset manufacturers and other optical component suppliers. The firm plans to use newly raised funds to accelerate QLC development, broaden market reach, and deepen collaborations with industry partners. Founded in 2018 by Chiara Greganti, Jonas Zeuner, and Nobel laureate Anton Zeilinger, Vitrealab is currently led by CEO Ronny Timmreck. Financial details beyond the latest capital injection were not disclosed in the article.

Participated · Seed · Sep 2025

hypt builds a proprietary word-of-mouth manager SaaS that helps enterprise customers systematically activate satisfied customers through real-time feedback collection, trustworthy online reviews and personal recommendations. The company focuses on enabling brands—especially in banking and insurance—to harness word-of-mouth as a growth channel. Since launch it has secured clients in Switzerland including UBS, Raiffeisen, die Mobiliar, Nestlé, Sanitas, PostFinance, CONCORDIA and ImmoScout24. Founded in May 2022 and based in Bern, hypt plans to use new funding to improve product development and drive growth in the DACH region. The product and go-to-market target enterprise needs for managing referrals and online reputation. Current financial details beyond the announced seed raise were not disclosed in the article. Hypt, founded in 2021 and based in Bern, provides a gamified chatbot solution that drives word-of-mouth in the app era. The software prompts users for feedback and the chatbot responds based on the rating, encouraging satisfied users to send editable "Personal Media Ads" recommending products, services, or advisors. Those ads include links that open webshops or landing pages and generate direct, measurable revenue. The company has secured enterprise customers including Rivella, Helvetia, Post, CSS and the Berner Kantonalbank, and reports roughly 50,000 users with a 40% recommendation rate. Hypt currently employs 13 people. The team plans to expand across the DACH region and enter the U.S. market within three years.

Participated · Equity · Nov 2024

mediaire builds AI-powered diagnostic solutions for MRI imaging, including products mdbrain, mdprostate, and mdknee, designed for seamless integration into clinical workflows. Its software provides automated decision support to improve diagnostic accuracy and optimize workflow efficiency. The company reports deployment in over 350 hospitals and clinics across Europe and daily use by radiologists in hundreds of institutions. mediaire says the funding will let it expand its AI portfolio beyond brain, prostate, and knee diagnostics to additional MRI applications. The company highlights partnerships with university hospitals and industry players such as Bayer/Calantic, Sectra, deepc, and radiology chains including Med360, Evidia, Starvision, and RIMED/UNILABS. With a stronger product pipeline and international presence, mediaire is positioning to scale its clinical footprint and commercial reach. mediaire develops mdbrain, an AI- and deep-learning-powered software that performs quantitative MRI analysis to accelerate brain-volume quantification and detect brain lesions. The software integrates into customers' local IT systems, providing an objective second opinion within minutes while emphasizing data protection. mediaire is certified per DIN EN ISO 13485:2016, which enables commercialization of mdbrain in Europe with a CE mark. In December 2020 an international investor pool including High‑Tech Gründerfonds (HTGF), primeCROWD and LIFTT invested approximately €2 million in a seed capital increase to support growth. The company plans European expansion beginning in 2021 (after initial deployments in Germany, Switzerland and Austria in 2020), further international expansion by 2023, and a product portfolio extension into areas such as knee and prostate. Proceeds will be used to scale sales & marketing, build a commercial network, further develop the product range and pursue upselling; headcount is expected to reach about 150 employees by 2025. mediaire builds mdbrain, a software-as-a-service that automates time-consuming radiology tasks and quantifies brain regions from MRI scans to support dementia diagnostics. The product was developed after a radiologist requested automated evaluation of brain regions and a working prototype validated demand in practice. The company charges most customers roughly €10–15 per analysis, with pricing dependent on monthly volume, and offers free trial access plus complimentary installation and service. mediaire positions its solution to reduce quality losses from radiologists’ rising image workloads and extremely short per-image review times. The startup has participated in the Science4Life business-plan competition and employs 16 people. Financially, it has already received funding support as it prepares a Series A round targeted for 2020. mediaire develops a fully automated software solution that delivers precise examination results and diagnostic suggestions within minutes to aid early detection of neurodegenerative diseases such as Alzheimer’s and Multiple Sclerosis. The system uses deep learning methods to detect and evaluate biomarkers, designed to achieve high-quality results with only a limited number of annotated data. The software is fully integrated into the IT system of the radiological practice so patient data never leaves the practice. This integration enables radiologists to provide diagnostic support while the patient is still in the practice. The company was founded in April 2018 and is based in Berlin, Germany. Financially, mediaire raised a six-digit euro funding round backed by High‑Tech Gründerfonds and a group of private investors represented by Sebastian Burian.